ACR Guidelines:DMARDs for Treatment of RA

• Currently included in Guidelines:

  • methotrexate
  • sulfasalazine
  • hydroxychloroquine
  • gold salts
  • D-penicillamine
  • azathioprine

• Not yet included in Guidelines:

  • leflunomide

Previous slide

Next slide

Back to first slide

View graphic version